NEW YORK (GenomeWeb News) — Accelrys today reported a 4 percent increase in revenues for its fourth fiscal quarter and a 2 percent increase for its full fiscal year.
The company said that its planned merger with scientific software firm Symyx, announced last month, has cleared the waiting period under Hart-Scott-Rodino antitrust regulations and is on track to close in early July.